Welcome to Creative Biolabs, your trusted partner in cutting-edge preclinical research. We offer a specialized and comprehensive service for the Allergenicity Assessment of Probiotics in Animal Models. As the probiotic market continues its rapid expansion, ensuring the safety and non-allergenic nature of these beneficial microorganisms is paramount for consumer health and regulatory compliance. Our state-of-the-art facilities, experienced scientific team, and robust methodologies provide accurate, reliable, and actionable data to support your product development and regulatory submissions. Our service is designed to identify potential allergenic responses induced by novel or existing probiotic strains, helping you mitigate risks, accelerate market entry, and build consumer confidence. Request a quote
Our service is designed to identify and characterize the allergenic potential of probiotic strains or multi-strain formulations using established and validated animal models. We employ a multi-faceted approach, integrating clinical observations, immunological assays, histopathological analyses, and molecular techniques to provide a holistic understanding of your product's safety profile. This comprehensive assessment is crucial for novel probiotic candidates, strain modifications, or new applications that require thorough safety substantiation.
Upon completion of the service, you will receive:
Deliverable Components | Content Specifications |
---|---|
Raw Data |
|
Analyzed Data |
|
Comprehensive Final Report |
|
Histopathology Slides/Images |
|
The typical turnaround time for a comprehensive allergenicity assessment study ranges from 12 to 20 weeks, depending on the complexity of the study design, number of endpoints, and animal model chosen. We will provide a precise timeline during the initial consultation.
Contact Us Today for a Quote.
Our team comprises highly experienced immunologists, microbiologists, and toxicologists with extensive knowledge in probiotic research and allergenicity assessment.
Flexible study designs tailored to your unique probiotic strain, research objectives, and regulatory pathway.
Studies were conducted per Good Laboratory Practice principles and relevant regulatory guidelines to ensure data acceptability for submissions.
Integration of clinical, immunological, and histopathological endpoints for a holistic understanding of allergenic potential.
A dedicated project manager will ensure seamless communication and timely updates throughout the study.
Strict adherence to confidentiality agreements to protect your proprietary information.
With the rising prevalence of food allergies and sensitivities, regulatory bodies and consumers alike demand stringent safety evaluations for novel food ingredients and dietary supplements. Probiotics, being living microorganisms, can potentially express proteins or metabolites that may trigger immune responses in susceptible individuals. A thorough allergenicity assessment is crucial for:
Ensure the safety and market readiness of your probiotic innovations. Contact Creative Biolabs today to discuss your specific allergenicity assessment needs and receive a customized quote. Our expert team is ready to partner with you to achieve your research and development goals.
We primarily utilize well-established murine models, such as BALB/c and C57BL/6 mice, due to their well-characterized immune responses and suitability for allergenicity studies. Other models can be considered based on specific project needs.
Yes, we can design studies to compare the allergenic potential of multiple probiotic strains or different formulations in a single study, optimizing efficiency and cost.
The dose is determined during the study design phase, taking into account the human equivalent dose, the intended use of the probiotic, and established guidelines. We aim to use physiologically relevant doses.
We can assess the allergenic potential of multi-strain probiotic formulations. The study design will be adapted to account for the complexity of the mixture.
Yes, we offer preliminary in vitro screening services (e.g., mast cell degranulation assays, basophil activation tests, cytokine production in immune cells), which can help prioritize strains for in vivo assessment and provide initial insights. This can be discussed during the consultation.
For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.
Copyright © 2025 Creative Biolabs. All Rights Reserved.